**About the Editor**

**Junji Uchino** (M.D., Ph.D.) is currently working as an associate professor in the Department of Respiratory Medicine, Kyoto Prefectural University of Medicine. He graduated from Nagasaki University in 1999, admitted to Kyushu University Graduate School of Medicine in 2002 to engage in gene therapy research, and in 2006, he was awarded a PhD due to the results of research on adenovirus-induced lung cancer gene therapy. He has been studying at the University of Washington, St. Louis for 2 years since 2012, to develop gene therapy research for lung cancer. He has been working with the Department of Respiratory Medicine, Kyoto Prefectural University of Medicine, since 2016. He has set up a clinical trial group that is leading a multi-center clinical trial, has drafted a multi-investigator-initiated trial, and has gained a total of \$5 million for consigned study as a principal investigator. Since 2020, he has also served as a guest editor in the journal *Frontiers Oncology*.
